메뉴 건너뛰기




Volumn 56, Issue 9, 2006, Pages 397-400

Assessment of resistance in multi drug resistant tuberculosis patients

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

EID: 34248633090     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (24)

References (21)
  • 1
    • 0031021203 scopus 로고    scopus 로고
    • Cohn DL, Bustreo F, Raviglione MC. Drug resistant tuberculosis: review of worldwide situation the WHO/IUATLD Global Surveillance project. International Union Against Tuberculosis and Lung Disease. Clin Inf Dis 1997; 24Suppl 1:S121-30.
    • Cohn DL, Bustreo F, Raviglione MC. Drug resistant tuberculosis: review of worldwide situation the WHO/IUATLD Global Surveillance project. International Union Against Tuberculosis and Lung Disease. Clin Inf Dis 1997; 24Suppl 1:S121-30.
  • 2
    • 0035953598 scopus 로고    scopus 로고
    • Global trend in resistance to antituberculous drugs. N Engl J Med 2001:344 1294-
    • Global trend in resistance to antituberculous drugs. N Engl J Med 2001:344 1294-
  • 3
    • 0033838178 scopus 로고    scopus 로고
    • Methicillin resistant Staphylococcus aureus and multi-drug resistant tuberculosis: Part 2
    • Patel D, Madan I. Methicillin resistant Staphylococcus aureus and multi-drug resistant tuberculosis: Part 2. Occup Med (Lond) 2000; 50: 395-7.
    • (2000) Occup Med (Lond) , vol.50 , pp. 395-397
    • Patel, D.1    Madan, I.2
  • 4
    • 0031061589 scopus 로고    scopus 로고
    • Primary resistance to anti tuberculosis drugs in Addis Ababa, Ethopia
    • Demissie M, Gebeyehu M, Berhane Y. Primary resistance to anti tuberculosis drugs in Addis Ababa, Ethopia. Int J Tuberc Lung Dis 1997; 1: 64-7.
    • (1997) Int J Tuberc Lung Dis , vol.1 , pp. 64-67
    • Demissie, M.1    Gebeyehu, M.2    Berhane, Y.3
  • 5
    • 34248648340 scopus 로고    scopus 로고
    • Anti-tuberculosis drug resistance in the world prevalence and trends
    • Anti-tuberculosis drug resistance in the world prevalence and trends.
  • 7
    • 34248657449 scopus 로고    scopus 로고
    • World Health Organization TB epidemiological profile as of 01-Jun-2005. www.who.int/globalatlas/predifinedreports/TB/PDF_files/pak_2003_brief.pdf (accessed in November 2005).
    • World Health Organization TB epidemiological profile as of 01-Jun-2005. www.who.int/globalatlas/predifinedreports/TB/PDF_files/pak_2003_brief.pdf (accessed in November 2005).
  • 8
    • 6344284100 scopus 로고    scopus 로고
    • Multi-drug resistant tuberculosis in Northern Pakistan
    • Butt T, Ahmed RN, Kazmi SY, Rafi N. Multi-drug resistant tuberculosis in Northern Pakistan. J Pak Med Assoc 2004; 54: 469-72.
    • (2004) J Pak Med Assoc , vol.54 , pp. 469-472
    • Butt, T.1    Ahmed, R.N.2    Kazmi, S.Y.3    Rafi, N.4
  • 10
    • 34248663677 scopus 로고    scopus 로고
    • Espinal MA, Simonsen L, Laszlo A, Boulahbal F, Kim SJ, Reneiro A, et al., for the WHO/International Union Against Tuberculosis and Lung Disease Global Working Group on Anti-tuberculosis Drug Resistance Surveillance. Anti- tuberculosis drug resistance in the world. Report No. 2. Geneva: World Health Organization; 2000. Unpublished document WHO/TB/2000.278. Available from: URL: http://www.who.int/gtb/publications/ drugresistance/ PDF/fullversion.pdf (accessed in November 2005).
    • Espinal MA, Simonsen L, Laszlo A, Boulahbal F, Kim SJ, Reneiro A, et al., for the WHO/International Union Against Tuberculosis and Lung Disease Global Working Group on Anti-tuberculosis Drug Resistance Surveillance. Anti- tuberculosis drug resistance in the world. Report No. 2. Geneva: World Health Organization; 2000. Unpublished document WHO/TB/2000.278. Available from: URL: http://www.who.int/gtb/publications/ drugresistance/ PDF/fullversion.pdf (accessed in November 2005).
  • 11
    • 34248649485 scopus 로고    scopus 로고
    • WHO Report 2002.Global Tuberculosis Control: Surveillance, Planning, Financing WHO/CDS/TB/2002.295 (accessed in November 2005).
    • WHO Report 2002.Global Tuberculosis Control: Surveillance, Planning, Financing WHO/CDS/TB/2002.295 (accessed in November 2005).
  • 12
    • 34248643904 scopus 로고    scopus 로고
    • Anti-tuberculous drug resistance in the world. The WHO/IUATLD Global project on antituberculous drug resistance surveillance 1994-1997.WHO/TB/97.229. Geneva: World Health Organization, 1997.
    • Anti-tuberculous drug resistance in the world. The WHO/IUATLD Global project on antituberculous drug resistance surveillance 1994-1997.WHO/TB/97.229. Geneva: World Health Organization, 1997.
  • 13
    • 34248646141 scopus 로고    scopus 로고
    • accessed in December
    • WHO/Annex1.www.who.int/tb/publications/global_report/2005/ annex1/en/index13.html (accessed in December 2005).
    • (2005) WHO/Annex1
  • 14
    • 0027386972 scopus 로고
    • Drug resistance of Mycobacterium tuberculosis in Karachi, Pakistan
    • Khan J, Islam N, Ajanee N, Jafri W. Drug resistance of Mycobacterium tuberculosis in Karachi, Pakistan. Tropical doctor 1993: 23: 13-14.
    • (1993) Tropical doctor , vol.23 , pp. 13-14
    • Khan, J.1    Islam, N.2    Ajanee, N.3    Jafri, W.4
  • 15
    • 0030154301 scopus 로고    scopus 로고
    • Pulmonary tuberculosis in a BCG vaccinated area: Relationship of disease severity with immunological and hematological parameters and drug resistance patterns
    • Hussin R, Hasan R, Khurshid M, Sturm A W, Ellner J J and Dawood G.Pulmonary tuberculosis in a BCG vaccinated area: relationship of disease severity with immunological and hematological parameters and drug resistance patterns. Southeast Asian J Trop Med Public Health 1996;27:257-62.
    • (1996) Southeast Asian J Trop Med Public Health , vol.27 , pp. 257-262
    • Hussin, R.1    Hasan, R.2    Khurshid, M.3    Sturm, A.W.4    Ellner, J.J.5    Dawood, G.6
  • 16
    • 0033389983 scopus 로고    scopus 로고
    • Drug resistance Mycobacterium tuberculosis: A four years experience.J Pak Med Assoc
    • Karamat K A, Rafi S, Abbasi SA. Drug resistance Mycobacterium tuberculosis: A four years experience.J Pak Med Assoc 1999;49:262-5.
    • (1999) , vol.49 , pp. 262-265
    • Karamat, K.A.1    Rafi, S.2    Abbasi, S.A.3
  • 18
    • 34248667453 scopus 로고    scopus 로고
    • Sensitivity pattern of Mycobacterium tuberculosis at Lahore (Pakistan)
    • Haq M U, Awan SR, Khan S U, Saeed S, Iqbal R, Shabbir I et al. Sensitivity pattern of Mycobacterium tuberculosis at Lahore (Pakistan). Annals 2002;8:190-3.
    • (2002) Annals , vol.8 , pp. 190-193
    • Haq, M.U.1    Awan, S.R.2    Khan, S.U.3    Saeed, S.4    Iqbal, R.5    Shabbir, I.6
  • 20
    • 7644240334 scopus 로고    scopus 로고
    • The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short course chemotherapy for tuberculosis
    • Seung KJ, Gelmanova IE, Peremitin GG, Golubchikva VT, Pavlova VE, Sirotkina OB et al.The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short course chemotherapy for tuberculosis. Clin Inf Dis 2004; 39:1321-8.
    • (2004) Clin Inf Dis , vol.39 , pp. 1321-1328
    • Seung, K.J.1    Gelmanova, I.E.2    Peremitin, G.G.3    Golubchikva, V.T.4    Pavlova, V.E.5    Sirotkina, O.B.6
  • 21
    • 0346307739 scopus 로고    scopus 로고
    • Incidence of multi drug resistant tuberculosis in urban and rural India and implications for prevention
    • Almeida D, Rodrigues C, Udwadia ZF, Lalvani A, Gothi G.D, Mehta P et al. Incidence of multi drug resistant tuberculosis in urban and rural India and implications for prevention. Clin Inf Dis 2003; 36:e152-4.
    • (2003) Clin Inf Dis , vol.36
    • Almeida, D.1    Rodrigues, C.2    Udwadia, Z.F.3    Lalvani, A.4    Gothi, G.D.5    Mehta, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.